BioCentury
ARTICLE | Company News

IGI Inc. deal

January 3, 1995 8:00 AM UTC

IGI Inc. (IG) SmithKline Beecham exercised its option to continue to develop the Buena, N.J., company’s Novasome lipid vesicle encapsulation technology for potential use in certain SmithKline vaccine...